Stock CLXPF CYBIN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cybin Inc.

Equities

CLXPF

CA23256X4075

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
 04:00:00 2025-01-24 pm EST 		5-day change 1st Jan Change
10.03 USD -1.57% Intraday chart for Cybin Inc. +9.86% +13.72%
Jan. 15 Cybin, Segal Trials Collaborate to Advance Major Depressive Disorder Treatment MT
Jan. 15 Cybin Launches Strategic Clinical Site Partnerships to Support Paradigm, A Multinational Pivotal Phase 3 Program Evaluating Cyb003 for the Adjunctive Treatment of Major Depressive Disorder CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYBIN INC. Stock Cybin Inc.
201M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
113B -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
72.71B
ARGENX SE Stock argenx SE
39.89B
BIONTECH SE Stock BioNTech SE
28.32B -
BEIGENE, LTD. Stock BeiGene, Ltd.
23.67B -
  1. Stock Market
  2. Equities
  3. CLXPF Stock
  4. Charts Cybin Inc.
  5. Sector Chart